Add-on Acquisition • Life Science

Puracap Pharmaceutical Acquires Blu Caribe

On March 23, 2016, Puracap Pharmaceutical acquired life science company Blu Caribe

Acquisition Context

This is Puracap Pharmaceutical’s 2nd transaction in the Life Science sector.
This is Puracap Pharmaceutical’s 1st transaction in Puerto Rico.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	March 23, 2016
Target	Blu Caribe
Sector	Life Science
Buyer(s)	Puracap Pharmaceutical
Deal Type	Add-on Acquisition

Target Company

Blu Caribe

Dorado, Puerto Rico

Blu Caribe, Inc. is a manufacturer and distributor of quality generic pharmaceuticals products.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Puracap Pharmaceutical

South Plainfield, New Jersey, United States

Category	Company
Sector	Life Science

DESCRIPTION

Puracap Pharmaceutical LLC is a pharmaceutical company, that provides product development, manufacturing and distribution bringing, quality products & services.

Deal Context for Buyer	#
Overall	2 of 2
Sector: Life Science	2 of 2
Type: Add-on Acquisition	2 of 2
Country: Puerto Rico	1 of 1
Year: 2016	2 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2016-03-23	Blu Pharmaceuticals Franklin, Kentucky, United States Blu Pharmaceuticals LLC is a manufacturer and distributor of pharmaceutical products.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2016-03-23

Blu Pharmaceuticals

Franklin, Kentucky, United States

Blu Pharmaceuticals LLC is a manufacturer and distributor of pharmaceutical products.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Puerto Rico M&A - 2016 M&A